0001694665-23-000154.txt : 20230913 0001694665-23-000154.hdr.sgml : 20230913 20230913205453 ACCESSION NUMBER: 0001694665-23-000154 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230911 FILED AS OF DATE: 20230913 DATE AS OF CHANGE: 20230913 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: McHale Duncan CENTRAL INDEX KEY: 0001738896 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38473 FILM NUMBER: 231253887 MAIL ADDRESS: STREET 1: C/O EVELO BIOSCIENCES, INC. STREET 2: 620 MEMORIAL DRIVE, SUITE 200 CITY: CAMBRIDGE STATE: MA ZIP: 02139 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Evelo Biosciences, Inc. CENTRAL INDEX KEY: 0001694665 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 465594527 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 620 MEMORIAL DRIVE SUITE 500 CITY: CAMBRIDGE STATE: MA ZIP: 02139 BUSINESS PHONE: 617-577-0300 MAIL ADDRESS: STREET 1: 620 MEMORIAL DRIVE SUITE 500 CITY: CAMBRIDGE STATE: MA ZIP: 02139 4 1 wk-form4_1694652884.xml FORM 4 X0508 4 2023-09-11 0 0001694665 Evelo Biosciences, Inc. EVLO 0001738896 McHale Duncan C/O EVELO BIOSCIENCES, INC. 620 MEMORIAL DRIVE CAMBRIDGE MA 02139 0 1 0 0 Chief Medical Officer 0 Restricted Stock Units 2023-09-11 4 A 0 37500 0 A Common Stock 37500 37500 D Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of Issuer common stock. The RSUs vest in three (3) substantially equal installments on each of November 1, 2023, February 1, 2024 and May 1, 2024, subject to the Reporting Person's continued service to the Issuer on each such vesting date. These RSUs have no expiration date. /s/ Marella Thorell, Attorney-in-Fact for Duncan McHale 2023-09-13